These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15870551)

  • 1. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
    Martínez J; Cid AR; de la Rubia J; Gimeno R
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.
    Moscardó F; Pérez F; de la Rubia J; Balerdi B; Lorenzo JI; Senent ML; Aznar I; Carceller S; Sanz MA
    Br J Haematol; 2001 Jul; 114(1):174-6. PubMed ID: 11472364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
    Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
    Franchini M; Manzato F; Salvagno GL; Lippi G
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation.
    Chuansumrit A; Chantarojanasiri T; Isarangkura P; Teeraratkul S; Hongeng S; Hathirat P
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S101-5. PubMed ID: 10850573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
    Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
    Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
    Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.
    Laffan MA; Tait RC; Blatný J; Espersen K; Grabowska I; Loch-Bakoñska L; Pauzkowska A; Stasiak-Pikula E; Michalska G; Wendon J; Piotrowska K
    Pancreas; 2005 Apr; 30(3):279-84. PubMed ID: 15782108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septic miscarriage with toxic shock syndrome and disseminated intravascular coagulation (DIC): The role of surgery, recombinant activated factor VII and intravenous immunoglobulin (IVIG).
    Tan LN; Mariappa G; Voon HY; Suharjono H
    Med J Malaysia; 2017 Dec; 72(6):380-381. PubMed ID: 29308782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation.
    Zhuang JL; Jiang QW; Xu Y; Wang SJ
    Chin Med J (Engl); 2011 Oct; 124(19):3189-91. PubMed ID: 22040579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidotes to haemorrhage: recombinant factor VIIa.
    Kessler CM
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
    Holub Z; Feyereisl J; Kabelík L; Rittstein T
    Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of recombinant factor VIIa.
    Roberts HR; Monroe DM; Hoffman M
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):101-8. PubMed ID: 14872430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bleeding associated with septic shock treated successfully with recombinant activated factor VII: a case report].
    Del Cojo Peces E; Torrado Criado MD; Macías Pingarrón JP; Negrete Calderón N
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):301-3. PubMed ID: 15968911
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
    Payne EM; Brett SJ; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
    Grounds RM; Bolan C
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S29-36. PubMed ID: 16221317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.